Page last updated: 2024-10-26

racemetirosine and Degenerative Diseases, Central Nervous System

racemetirosine has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhou, Z1
Kerk, S1
Meng Lim, T1

Other Studies

1 other study available for racemetirosine and Degenerative Diseases, Central Nervous System

ArticleYear
Endogenous dopamine (DA) renders dopaminergic cells vulnerable to challenge of proteasome inhibitor MG132.
    Free radical research, 2008, Volume: 42, Issue:5

    Topics: alpha-Methyltyrosine; Animals; Cell Survival; Cysteine Proteinase Inhibitors; Dopamine; Leupeptins;

2008